Logo image of ACTU

ACTUATE THERAPEUTICS INC (ACTU) Stock Analyst Earnings Estimates

NASDAQ:ACTU - Nasdaq - US0050831009 - Currency: USD

6.95  +0.01 (+0.14%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
ACTU revenue by date.ACTU revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
ACTU ebitda by date.ACTU ebitda by date.
N/AN/AN/AN/AN/A
EBIT
YoY % growth
ACTU ebit by date.ACTU ebit by date.
-20.207M-24.974M
-23.59%
N/A
1.16%
N/A
-25.62%
N/A
-40.13%
Operating Margin
ACTU operating margin by date.ACTU operating margin by date.
N/AN/AN/AN/AN/A
EPS
YoY % growth
ACTU eps by date.ACTU eps by date.
N/AN/AN/AN/A
62.03%
N/A
-24.17%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
-0.30
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-5.712M
77.13%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
ACTU Yearly EPS VS EstimatesACTU Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -1 -2 -3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
ACTU Yearly Revenue VS EstimatesACTU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% N/A
RevenueN/A N/A N/A N/A